Skip to main content
. 2023 Mar 11;15(3):921. doi: 10.3390/pharmaceutics15030921

Figure 8.

Figure 8

Duration of catalepsy after intranasal administration (s). * p < 0.05—Statistically significant difference compared to the haloperidol group. # 0.05 < p < 0.1—Significance trend compared to haloperidol group.